233 related articles for article (PubMed ID: 18477668)
1. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.
Trivedi RN; Wang XH; Jelezcova E; Goellner EM; Tang JB; Sobol RW
Mol Pharmacol; 2008 Aug; 74(2):505-16. PubMed ID: 18477668
[TBL] [Abstract][Full Text] [Related]
2. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
[TBL] [Abstract][Full Text] [Related]
3. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
[TBL] [Abstract][Full Text] [Related]
4. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
Goellner EM; Grimme B; Brown AR; Lin YC; Wang XH; Sugrue KF; Mitchell L; Trivedi RN; Tang JB; Sobol RW
Cancer Res; 2011 Mar; 71(6):2308-17. PubMed ID: 21406402
[TBL] [Abstract][Full Text] [Related]
5. Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells.
Rinne M; Caldwell D; Kelley MR
Mol Cancer Ther; 2004 Aug; 3(8):955-67. PubMed ID: 15299078
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.
Stachelek GC; Dalal S; Donigan KA; Campisi Hegan D; Sweasy JB; Glazer PM
Cancer Res; 2010 Jan; 70(1):409-17. PubMed ID: 20028873
[TBL] [Abstract][Full Text] [Related]
7. Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
Tentori L; Turriziani M; Franco D; Serafino A; Levati L; Roy R; Bonmassar E; Graziani G
Leukemia; 1999 Jun; 13(6):901-9. PubMed ID: 10360379
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide: mechanisms of action, repair and resistance.
Zhang J; Stevens MF; Bradshaw TD
Curr Mol Pharmacol; 2012 Jan; 5(1):102-14. PubMed ID: 22122467
[TBL] [Abstract][Full Text] [Related]
9. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.
Agnihotri S; Burrell K; Buczkowicz P; Remke M; Golbourn B; Chornenkyy Y; Gajadhar A; Fernandez NA; Clarke ID; Barszczyk MS; Pajovic S; Ternamian C; Head R; Sabha N; Sobol RW; Taylor MD; Rutka JT; Jones C; Dirks PB; Zadeh G; Hawkins C
Cancer Discov; 2014 Oct; 4(10):1198-213. PubMed ID: 25100205
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells.
Jaiswal AS; Banerjee S; Panda H; Bulkin CD; Izumi T; Sarkar FH; Ostrov DA; Narayan S
Mol Cancer Res; 2009 Dec; 7(12):1973-83. PubMed ID: 19996303
[TBL] [Abstract][Full Text] [Related]
11. N-methylpurine DNA glycosylase inhibits p53-mediated cell cycle arrest and coordinates with p53 to determine sensitivity to alkylating agents.
Song S; Xing G; Yuan L; Wang J; Wang S; Yin Y; Tian C; He F; Zhang L
Cell Res; 2012 Aug; 22(8):1285-303. PubMed ID: 22801474
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
Fishel ML; He Y; Smith ML; Kelley MR
Clin Cancer Res; 2007 Jan; 13(1):260-7. PubMed ID: 17200364
[TBL] [Abstract][Full Text] [Related]
13. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses.
Sobol RW; Kartalou M; Almeida KH; Joyce DF; Engelward BP; Horton JK; Prasad R; Samson LD; Wilson SH
J Biol Chem; 2003 Oct; 278(41):39951-9. PubMed ID: 12882965
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells.
Tentori L; Portarena I; Torino F; Scerrati M; Navarra P; Graziani G
Glia; 2002 Oct; 40(1):44-54. PubMed ID: 12237842
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial transcription factor A (TFAM) has 5'-deoxyribose phosphate lyase activity in vitro.
Zhao W; Hussen AS; Freudenthal BD; Suo Z; Zhao L
DNA Repair (Amst); 2024 May; 137():103666. PubMed ID: 38492429
[TBL] [Abstract][Full Text] [Related]
17. Alkylation sensitivity screens reveal a conserved cross-species functionome.
Svilar D; Dyavaiah M; Brown AR; Tang JB; Li J; McDonald PR; Shun TY; Braganza A; Wang XH; Maniar S; St Croix CM; Lazo JS; Pollack IF; Begley TJ; Sobol RW
Mol Cancer Res; 2012 Dec; 10(12):1580-96. PubMed ID: 23038810
[TBL] [Abstract][Full Text] [Related]
18. DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.
Jaiswal AS; Banerjee S; Aneja R; Sarkar FH; Ostrov DA; Narayan S
PLoS One; 2011 Feb; 6(2):e16691. PubMed ID: 21311763
[TBL] [Abstract][Full Text] [Related]
19. NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells.
Jaiswal AS; Panda H; Law BK; Sharma J; Jani J; Hromas R; Narayan S
PLoS One; 2015; 10(5):e0123808. PubMed ID: 25933036
[TBL] [Abstract][Full Text] [Related]
20. Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing.
Fishel ML; Seo YR; Smith ML; Kelley MR
Cancer Res; 2003 Feb; 63(3):608-15. PubMed ID: 12566303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
